These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2117625)

  • 21. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical efficacy of pegylated interferon in patients co-infected with HIV and HCV who failed standard interferon therapy].
    Ke YC; Li LH; Hu FY; He Y; Lan Y; Chen XJ; Tang XP; Cai WP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):181-5. PubMed ID: 27095760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.
    Legrand E; Neau D; Galperine T; Trimoulet P; Moreau JF; Pitard V; Lacut JY; Ragnaud JM; Dupon M; Le Bail B; Bernard N; Schvoerer E; Houghton M; Fleury H; Lafon ME
    J Infect Dis; 2002 Aug; 186(3):302-11. PubMed ID: 12134226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
    Mulder JW; Lange JM; de Wolf F; Houweling JT; Bakker M; Coutinho RA; Goudsmit J
    Neth J Med; 1990 Aug; 37(1-2):4-10. PubMed ID: 2120599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
    Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
    Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection. Spanish Ribavirin Trial Group.
    Lancet; 1991 Jul; 338(8758):6-9. PubMed ID: 1676117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surrogate markers for AIDS treatment.
    Jacobson M
    Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex.
    Pialoux G; Youle M; Dupont B; Gazzard B; Cauwenbergh GF; Stoffels PA; Davies S; de Saint Martin J; Janssen PA
    Lancet; 1991 Jul; 338(8760):140-3. PubMed ID: 1677064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I study of ampligen in human immunodeficiency virus-infected subjects.
    Armstrong JA; McMahon D; Huang XL; Pazin GJ; Gupta P; Rinaldo CR; Schoenfeld DA; Gaccione P; Tripoli CA; Bensasi S
    J Infect Dis; 1992 Oct; 166(4):717-22. PubMed ID: 1527407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients.
    Rinaldo C; Huang XL; Piazza P; Armstrong J; Rappocciolo G; Pazin G; McMahon D; Gupta P; Fan Z; Zhang Z
    J Infect Dis; 1991 Oct; 164(4):638-45. PubMed ID: 1680135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction.
    Mermin JH; Holodniy M; Katzenstein DA; Merigan TC
    J Infect Dis; 1991 Oct; 164(4):769-72. PubMed ID: 1680138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
    Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichosanthin treatment of HIV-induced immune dysregulation.
    Mayer RA; Sergios PA; Coonan K; O'Brien L
    Eur J Clin Invest; 1992 Feb; 22(2):113-22. PubMed ID: 1572389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex.
    Dolin R; Lambert JS; Morse GD; Reichman RC; Plank CS; Reid J; Knupp C; McLaren C; Pettinelli C
    Rev Infect Dis; 1990; 12 Suppl 5():S540-9; discussion S549-51. PubMed ID: 1974726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
    Berglund O; Engman K; Ehrnst A; Andersson J; Lidman K; Akerlund B; Sönnerborg A; Strannegård O
    J Infect Dis; 1991 Apr; 163(4):710-5. PubMed ID: 1672701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
    McKinney RE; Maha MA; Connor EM; Feinberg J; Scott GB; Wulfsohn M; McIntosh K; Borkowsky W; Modlin JF; Weintrub P
    N Engl J Med; 1991 Apr; 324(15):1018-25. PubMed ID: 1672443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men.
    van Griensven GJ; de Vroome EM; de Wolf F; Goudsmit J; Roos M; Coutinho RA
    Am J Epidemiol; 1990 Aug; 132(2):203-10. PubMed ID: 1973594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.
    Nishanian P; Huskins KR; Stehn S; Detels R; Fahey JL
    J Infect Dis; 1990 Jul; 162(1):21-8. PubMed ID: 2113075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.